The Online Investor
Home
Dividends
25 Safe Dividends
Stock Splits
Mergers & Acquisitions
Mega Mergers
Stock Buybacks
Stock Buybacks
Contrarian Outlook
Stock Option Ideas
Preferred Stock Newsletter
ChartZero.com
IPOs
Secondary Offerings
Top 20 Large Caps
Top 20 Biggest ETFs
Insider Buying
Top 25 Low PE Ratios
Analyst Actions
25 Top Analyst Picks
Articles
CAGR Calculator
Dunnan On Dollars
10 Pot Stocks
ETF Center
Knowledge Center
Retirement Center
Advertising Opportunities
Privacy Policy
Disclaimer Statement
ABMD Buyback image

Abiomed, Inc. Buyback

OLI recorded this information on 11/13/2012

Company: Abiomed, Inc.
Buyback: ABMD buyback
$Amount Authorized: $15,000,000
Buyback Details: Abiomed, Inc., a leading provider of breakthrough heart support technologies, today announced that its Board of Directors has authorized a stock repurchase program of up to $15 million of its common stock.

ABIOMED is a provider of medical devices that provide circulatory support and oxygenation. Co.'s existing products include: Impella 2.5®, which is a percutaneous heart pump with a motor and sensors; Impella CP®, which is primarily used by either interventional cardiologists to support patients in the cath lab or by cardiac surgeons in the heart surgery suite; Impella 5.0® and Impella LD®, which are percutaneous heart pumps with motors and sensors for use primarily in the heart surgery suite; Impella 5.5®, which is designed to be a percutaneous heart pump with motors and sensors; and Abiomed Breethe OXY-1 System, which is a portable external respiratory assistance device.
Open the ABMD Page at The Online Investor »

ABMD — Key Stats (updated Wed., Dec. 21, 10:19 AM)
Company Name:  ABIOMED, Inc.
Stock buyback:  ABMD buyback
Website:  www.abiomed.com
Sector:  Medical Instruments & Supplies
 

Open the ABMD Page at The Online Investor (in a new window) »
April 18, 2024  •  7:31 AM Eastern
ABMD — Current Quote
Quotes delayed 20 minutes

Email EnvelopeFree ABMD Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts
Avg. Broker Rec.

Hold (2.40 out of 4)
100th percentile
(ranked higher than approx. 100% of all stocks covered)

Analysts' Target Price:
ABMD Stock Forecast

 Based on Zacks ABR data;
powered by Xignite

ABMD Buyback | www.TheOnlineInvestor.com | Copyright © 1998 - 2024, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.